APR 14, 2026 · JOURNAL ARTICLE
Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.
Annals of Medicine
Observational comparative effectiveness study with IPTW adjustment showing aspirin associated with lower mortality than alternatives in diabetic PAD patients with foot disease, but findings are from registry data without randomization and require prospective verification.
Reported
Sample size2597
MALE (cilostazol vs aspirin)sHR 1.45 [95% CI 1.15–1.84]
MALE (clopidogrel vs aspirin)sHR 1.31 [95% CI 0.99–1.72]